Exclusive interview

Fabricant: Gap between NDI numbers and submissions is too big 'no matter how you slice it'

Related tags New dietary ingredients Food and drug administration

It might be controversial, but the FDA's draft guidance on new dietary ingredients (NDIs) does not mean the end of the dietary supplements trade as we know it, insists Daniel Fabricant in an exclusive interview with NutraIngredients-USA at SupplySide West.

Talking with Stephen Daniells, Dr Fabricant fielded questions on the FDA's assessment on the time required for a notification, a definite grandfathered list, FDA's resources to cope with an anticipated avalanche of submissions, probiotics, and much more...

Related topics Regulation & policy

Related news

Show more

Follow us


View more